Skip to main content

Silvant Capital Management LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1738728 ATLANTA, GA

Position in NBIX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$3,489,789
+$775,155 QoQ
Shares Held
20,706
+0.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#247
of 768 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Silvant Capital Management LLC holds $3,489,789 across 1 Drug Manufacturers - Specialty & Generic name. NBIX ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
20,706 $3,489,789

All Filings in NBIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,489,789 20,706
2026-03-31 $2,714,634 20,606
2025-12-31 $2,875,319 20,273
2025-09-30 $2,800,159 19,947
2025-06-30 $2,744,189 21,833
2025-03-31 $2,414,729 21,833
2024-12-31 $2,980,204 21,833
2024-09-30 $2,515,598 21,833
2024-06-30 $3,005,749 21,833
2024-03-31 $2,523,108 18,294
2023-12-31 $2,410,417 18,294
2023-09-30 $2,058,075 18,294
2023-06-30 $1,725,124 18,294
2023-03-31 $1,851,718 18,294
2022-12-31 $2,185,035 18,294